Patents by Inventor Josh Walker

Josh Walker has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11227005
    Abstract: Computing systems and related methods are provided for performing database actions responsive to input gestures made by a user. One exemplary method involves a server identifying a gesture on a graphical user interface display on a client device, identifying a subset of displayed content on the graphical user interface display corresponding to the gesture, determining a database action based on at least one of characteristics associated with the gesture and the gestured content, performing the database action with respect to an object in a database, and updating the gestured content on the graphical user interface display to reflect performance of the database action.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: January 18, 2022
    Inventor: Josh Walker
  • Publication number: 20180004780
    Abstract: Computing systems and related methods are provided for performing database actions responsive to input gestures made by a user. One exemplary method involves a server identifying a gesture on a graphical user interface display on a client device, identifying a subset of displayed content on the graphical user interface display corresponding to the gesture, determining a database action based on at least one of characteristics associated with the gesture and the gestured content, performing the database action with respect to an object in a database, and updating the gestured content on the graphical user interface display to reflect performance of the database action.
    Type: Application
    Filed: June 30, 2016
    Publication date: January 4, 2018
    Applicant: salesforce.com, inc.
    Inventor: Josh Walker
  • Patent number: 9828432
    Abstract: OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.
    Type: Grant
    Filed: February 6, 2012
    Date of Patent: November 28, 2017
    Assignee: PROVIDENCE HEALTH & SERVICES—OREGON
    Inventors: Brendan Curti, Magdalena Kovacsovics-Bankowski, Ed Walker, Josh Walker, Andy Weinberg
  • Publication number: 20150098942
    Abstract: OX40 is a potent immune stimulating target. Provided herein are methods for the treatment of cancer patients using (3X40 agonists methods to predict clinical outcome of the treatment by correlation of the treatment and an increase in OX40-induced T cell proliferation.
    Type: Application
    Filed: February 6, 2012
    Publication date: April 9, 2015
    Applicant: Providence Health & Services - Oregon d/b/a Providence Portland Medical Center
    Inventors: Brendan Curti, Magdalena Kovacsovics-Bankowski, Ed Walker, Josh Walker, Andy Weinberg